FDA warns about qualaquin use for restless leg syndrome
The Food and Drug Administration (FDA) has issued a warning to health care professionals to use extreme caution when prescribing Qualaquin (Quinine Sulfate), according to the Postmarket Reviews section of the Volume 2, Number 2 2, 2009 issue of its quarterly online newsletter, Drug Safety News (DSN).
![[ Beasley Allen Law Firm Logo ]](http://www.southerninjurylawyer.com/wp-content/themes/system-unity/images/logo.png)
